Lithera Announces Company Name Change to Neothetics, Inc.
12 août 2014 07h00 HE
|
Neothetics
SAN DIEGO, Aug. 12, 2014 (GLOBE NEWSWIRE) -- Lithera, Inc., announced today that it has changed its name to Neothetics, Inc. The new name strengthens the company's positioning as a clinical-stage,...
Lithera to Present at the 13th Annual Needham Healthcare Conference
02 avr. 2014 07h00 HE
|
Neothetics
SAN DIEGO, April 2, 2014 (GLOBE NEWSWIRE) -- Lithera, Inc. ("Lithera" or "the Company"), a clinical stage pharmaceutical company focused on lifestyle and medical indications in aesthetic medicine and...
Lithera to Present at Cowen and Company Health Care Conference
27 févr. 2014 07h00 HE
|
Neothetics
SAN DIEGO, Feb. 27, 2014 (GLOBE NEWSWIRE) -- Lithera, Inc. ("Lithera" or "the Company"), a clinical stage pharmaceutical company focused on lifestyle and medical indications in aesthetic medicine and...
Lithera Announces Final Closing of $35.6 Million Series C Financing
11 févr. 2014 07h00 HE
|
Neothetics
SAN DIEGO, Feb. 11, 2014 (GLOBE NEWSWIRE) -- Lithera, Inc. ("Lithera" or "the Company"), a clinical stage pharmaceutical company focused on lifestyle and medical indications in aesthetic medicine and...
Lithera Announces Appointment of Dermatology and Aesthetics Authority Dr. Lincoln Krochmal as Chief Medical Officer
21 nov. 2013 07h00 HE
|
Neothetics
SAN DIEGO, Nov. 21, 2013 (GLOBE NEWSWIRE) -- Lithera, Inc., a clinical stage pharmaceutical company focused on lifestyle and medical indications in aesthetic medicine and ophthalmology, today...
Lithera Reports Positive Clinical Study Results From Its Phase 2b RESET Trial for LIPO-202, a Novel Treatment for Abdominal Body Contouring
30 sept. 2013 07h00 HE
|
Neothetics
SAN DIEGO, Sept. 30, 2013 (GLOBE NEWSWIRE) -- Lithera, Inc., a clinical stage pharmaceutical company focused on lifestyle and medical indications in aesthetic medicine and ophthalmology, today...
Lithera Announces Second Closing of $27.3 Million Series C Financing
18 juil. 2013 07h00 HE
|
Neothetics
SAN DIEGO, July 18, 2013 (GLOBE NEWSWIRE) -- Lithera, Inc. ("Lithera" or "the Company"), a clinical stage pharmaceutical company focused on aesthetic and medical indications, today announced that it...
Lithera Announces Notice of Allowance for Key United States Patent Application for LIPO-202, Its Novel Product for Localized Fat Reduction
07 janv. 2013 09h00 HE
|
Neothetics
SAN DIEGO, Jan. 7, 2013 (GLOBE NEWSWIRE) -- Lithera, Inc. today announced receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for a patent application covering formulations and...
Lithera, Inc. Completes $20.6 Million Equity Financing
19 déc. 2012 09h00 HE
|
Neothetics
SAN DIEGO, Dec. 19, 2012 (GLOBE NEWSWIRE) -- Lithera, Inc. today announced investment of $20.6 million in preferred stock equity financing. Additional investment may provide the Company with up to a...
Lithera, Inc. Appoints Thomas Wiggans to Board of Directors
04 avr. 2011 09h00 HE
|
Neothetics
SAN DIEGO, April 4, 2011 (GLOBE NEWSWIRE) -- Lithera, Inc. announced today the appointment of Thomas G. Wiggans to its Board of Directors.
"Lithera is making substantial progress with LIPO-102 by...